The impact of silver ions on decrease in sputum viscosity among the patients with asthma
A. Lobanov (Moscow, Russian Federation), S. Andronov (Moscow, Russian Federation), E. Bogdanova (Severodvinsk, Russian Federation), A. Emelyanov (Saint-Petersburg, Russian Federation), A. Fesyun (Moscow, Russian Federation), A. Rachin (Moscow, Russian Federation), G. Barashkov (Moscow, Russian Federation), A. Nikitina (Moscow, Russian Federation), A. Popov (Nadym, Russian Federation)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lobanov (Moscow, Russian Federation), S. Andronov (Moscow, Russian Federation), E. Bogdanova (Severodvinsk, Russian Federation), A. Emelyanov (Saint-Petersburg, Russian Federation), A. Fesyun (Moscow, Russian Federation), A. Rachin (Moscow, Russian Federation), G. Barashkov (Moscow, Russian Federation), A. Nikitina (Moscow, Russian Federation), A. Popov (Nadym, Russian Federation). The impact of silver ions on decrease in sputum viscosity among the patients with asthma. 1829
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD Source: Eur Respir J 2014; 43: 1504-1506 Year: 2014
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
The positive effect of oral zinc sulphate on the sputum smear of patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004
Zinc and copper concentrations in the cell and biological fluids of patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 354s Year: 2004
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008
The relation of sputum color to bacterial load in exacerbations of COPD Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Bronchoscopic lung volume reduction with silver nitrate in patients with emphysema Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Excess mucus viscosity and airway dehydration impact COPD airway clearance Source: Eur Respir J, 55 (1) 1900419; 10.1183/13993003.00419-2019 Year: 2020
Effect of inhaled mannitol on the sputum properties in asthmatics with excessive secretions Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006
The success of obtaining the induced sputum of patients with COPD Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019
The use of induced sputum to study the correlation between size particles and pulmonary function tests (PFT) in workers exposed to silica and hard metals Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001
High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006
The effect of heparin nebulization on BAL cellularity and clinical evaluation in a long-time study in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002
Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001